← All organizations

Medicis

For profitContributed to NME

Also known as: MEDICIS | Medicis Global Service Corporation | Medicis Pharmaceutical | Medicis Pharmaceutical Corporation | MEDICIS PHARMS

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

First NDA

Last known activity

Sep 1, 2012

Acquired by Bausch Health Companies on Dec 11, 2012

Timeline

1980s

Jan 1, 1988
Medicis— Founded

1990s

Jan 1, 1997
GenDerm— Acquired
Jan 1, 1999
Ucyclyd— Acquired

2000s

Jul 12, 2002
prednisolone— Marketing Organization
Feb 11, 2005
fluocinonide— NDA Secondary Org
Jan 1, 2008
LipoSonix— Acquired

2010s

Jan 1, 2011
Graceway— Acquired
Dec 11, 2012
Bausch Health Companies— Acquired By
Nov 14, 2013
luliconazole— NDA Organization

Drugs by trial phase (37 distinct, 78 trials)

Phase 4 (7 own, 9 via acquisition)

Phase 3 (1 own, 5 via acquisition)

Phase 2 (1 own, 2 via acquisition)

Phase 1 (0 own, 8 via acquisition)

Other trials (0 own, 4 via acquisition)

Indications

Approved for

Studied for

Subsidiaries (4 direct, 5 total across the full acquisition tree)

Recent trials (25)

NCT01703793Lead sponsorPhase 2Sep 1, 2012
NCT01703793Study chairPhase 2Sep 1, 2012
NCT01621399Lead sponsorPhase 3May 1, 2012
NCT01621399Study directorPhase 3May 1, 2012
NCT01469767CollaboratorN/AFeb 1, 2012
NCT01401803CollaboratorPhase 4Sep 1, 2011
NCT01459666CollaboratorPhase 4Sep 1, 2011
NCT01396785Study directorPhase 3Jul 1, 2011
NCT01396785Lead sponsorPhase 3Jul 1, 2011
NCT01396811Study directorPhase 3Jul 1, 2011
NCT01413763Lead sponsorPhase 4Jul 1, 2011
NCT01396811Lead sponsorPhase 3Jul 1, 2011
NCT01342315Lead sponsorPhase 3May 1, 2011
NCT01342315Study directorPhase 3May 1, 2011
NCT01354743CollaboratorPhase 4Dec 1, 2010

Details

Founded: Scottsdale, AZ, US Jan 1, 1988
First NDA: Nov 14, 2013
Last known activity: Sep 1, 2012

Notes

Acquired by Valeant